<i>Ageratina adenophora</i> (Spreng.) King & H. Rob. Standardized leaf extract as an antidiabetic agent for type 2 diabetes: An <i>in vitro</i> and <i>in vivo</i> evaluation.

Chanu KD, Sharma N, Kshetrimayum V, Chaudhary SK, Ghosh S, Haldar PK, Mukherjee PK.

Open source

DOI
10.3389/fphar.2023.1178904
Published
2023-04-17
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2023.1178904,
  title = {<i>Ageratina adenophora</i> (Spreng.) King \& H. Rob. Standardized leaf extract as an antidiabetic agent for type 2 diabetes: An <i>in vitro</i> and <i>in vivo</i> evaluation.},
  author = {Chanu KD and  Sharma N and  Kshetrimayum V and  Chaudhary SK and  Ghosh S and  Haldar PK and  Mukherjee PK.},
  year = {2023},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2023.1178904},
  url = {https://doi.org/10.3389/fphar.2023.1178904}
}

RIS

TY  - JOUR
TI  - <i>Ageratina adenophora</i> (Spreng.) King & H. Rob. Standardized leaf extract as an antidiabetic agent for type 2 diabetes: An <i>in vitro</i> and <i>in vivo</i> evaluation.
AU  - Chanu KD
AU  -  Sharma N
AU  -  Kshetrimayum V
AU  -  Chaudhary SK
AU  -  Ghosh S
AU  -  Haldar PK
AU  -  Mukherjee PK.
PY  - 2023
JO  - Front Pharmacol
DO  - 10.3389/fphar.2023.1178904
UR  - https://doi.org/10.3389/fphar.2023.1178904
ER  - 

APA

KD, C., N, S., V, K., SK, C., S, G., PK, H., & PK., M. (2023). <i>Ageratina adenophora</i> (Spreng.) King & H. Rob. Standardized leaf extract as an antidiabetic agent for type 2 diabetes: An <i>in vitro</i> and <i>in vivo</i> evaluation.. Front Pharmacol. https://doi.org/10.3389/fphar.2023.1178904

Source records